
Johnson & Johnson Buys Firefly Bio for $1B
Johnson & Johnson (NYSE: JNJ) agreed to acquire Firefly Bio for $1 billion in cash, according to the company. The deal adds Firefly Bio’s Firelink degrader antibody conjugate (DAC) platform to J&J’s oncology portfolio. Firefly Bio develops targeted therapies aimed at delivering protein degraders to tumor cells, including preclinical candidates for KRAS-driven solid tumors.

AMD commits £2bn investment in UK AI, supercomputers and nuclear fusion
AMD said it will invest up to $2.7 billion (£2 billion) in the UK over five years, announced at London Tech Week, to support AI research and advanced computing. The plan includes funding two Cambridge supercomputers: Zenith for AI-for-science and Sunrise for fusion energy research. AMD also plans work with Imperial College London and Oriole Networks.

Marvell Technology pops after being promoted to S&P 500
Marvell Technology (NASDAQ:MRVL) shares rose about 10% in early trading after S&P Dow Jones Indices confirmed the stock will be added to the S&P 500 as part of its quarterly reshuffle, according to the index provider. The article notes the move typically triggers buying by index funds/ETFs. Marvell replaces Pool Corporation and Campbell’s Co when trading begins June 22.

Nexera Technologies Announces Pricing of $1.2 Million Registered Direct Offering and Concurrent Private Placement
Nexera Technologies Ltd (Nasdaq: NEXR) said it priced a $1.2 million registered direct offering of 1,200,000 ordinary shares at $1.00 each, with gross proceeds before expenses. In a concurrent private placement, it will issue warrants for up to 1,200,000 shares at a $1.00 exercise price, exercisable immediately and expiring in 5.5 years. Net proceeds will fund working capital, general purposes, and potential acquisitions; closing expected June 9, 2026.

Stock Market Live June 8, 2026: S&P 500 (SPY) Rebounds with Chip Stocks
The article says a late-week rotation out of semiconductor stocks drove a sharp selloff, with the Nasdaq down over 1,100 points, and the Dow and S&P 500 also falling. It reports a rebound today: S&P 500 up 0.74% (~55 points) and SPY up 0.75% (~$5.60). Citigroup raised its year-end S&P 500 target to 8,100, citing AI-driven earnings (est. $350/share in 2026, $400 in 2027). Marvell shares rose 9% after its June 22 S&P 500 inclusion; Bank of America raised Sandisk’s target to $2,100.

SanDisk Stock Has 35% More To Run, Analyst Says - SanDisk (NASDAQ:SNDK)
BofA reiterated a Buy rating on SanDisk (SNDK) and raised fiscal 2027 revenue and EPS estimates to $44.0B and $187.65. The bank set a $2,100 price target based on ~10x C27E EPS of $199, implying ~34.7% upside. BofA cited SanDisk’s multi-year “NBM” supply partnerships with fixed upfront pricing, $11B+ in guarantees, and supply constraints lasting until 2028–2029.